Improvement of in vitro efficacy of a novel schistosomicidal drug by incorporation into nanoemulsion's

被引:56
作者
Caldeira de Araújo, Savia
Alves de Mattos, Ana Carolina
Teixeira, Helder Ferreira
Zech Coelho, Paulo Marcos
Nelson, David Lee
de Oliveira, Monica Cristina
机构
[1] Univ Fed Minas Gerais, Fac Farm, Dept Prod Farmaceut, BR-31270901 Belo Horizonte, MG, Brazil
[2] Ctr Pesquisas Rene Rachou Fiocruz, Lab Esquistossomose, CPqRR Fiocruz, BR-1715 Belo Horizonte, MG, Brazil
[3] Univ Fed Rio Grande do Sul, Fac Farm, Dept Prod & Controle Medicamentos, BR-90610000 Porto Alegre, RS, Brazil
[4] Univ Fed Minas Gerais, Fac Farm, Dept Alimentos, BR-31270901 Belo Horizonte, MG, Brazil
关键词
schistosomiasis; 2-(butylamino)-1-phenyl-1-ethanethiosulfuric acid; nanoemulsions;
D O I
10.1016/j.ijpharm.2007.01.009
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim of this article included the development and evaluation of the capacity of nanoemulsions to improve the activity of the novel schistosomicidal drug-2-(butylamino)-1-phenyl-1-ethanethiosulfuric acid (BphEA). BphEA is a compound with a poor solubility in water, which makes its application as a drug difficult. Nanoemulsion formulations presenting anionic (NANOSTOA, NANOST and NANOLP) and cationic (NANOSTE) interfacial charges were prepared to encapsulate BphEA. These formulations were characterized by the encapsulation rate, diameter, and zeta potential. NANOSTOA, NANOST, and NANOLP presented an entrapment efficiency and zeta potential of 18.7 +/- 1.8% and -33.6 +/- 1.2 mV; 20.5 +/- 3.0% and -31.5 +/- 5.7 mV; as well as 33.8 +/- 7.2% and -62.6 +/- 1.3 mV, respectively. NANOSTE presented an entrapment efficiency of 51.8 +/- 5.0% and a zeta potential of 25.7 +/- 3.9 mV The mean droplet size (between 200 and 252 nm) and polydispersity index (between 0.158 and 0.294) were similar for all formulations. The stability study showed no alteration in these formulations' zeta potential and size. The in vitro schistosomicidal activity of BphEA was higher with the use of NANOSTE than with free BphEA. In addition, release studies revealed a good stability of NANOSTE containing BphEA in a biological medium. These results indicate that cationic nanoemulsions can represent an interesting delivery system for the pharmaceutical formulation of BphEA. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:307 / 315
页数:9
相关论文
共 23 条
[1]  
Blanchard Tom J, 2004, Travel Med Infect Dis, V2, P5, DOI 10.1016/j.tmaid.2004.02.011
[2]   Altered response of strain of Schistosoma mansoni to oxamniquine and praziquantel [J].
Bonesso-Sabadini, PIP ;
de Souza Dias, LC .
MEMORIAS DO INSTITUTO OSWALDO CRUZ, 2002, 97 (03) :381-385
[3]   Nano-emulsion formulation using spontaneous emulsification:: solvent, oil and surfactant optimisation [J].
Bouchemal, K ;
Briançon, S ;
Perrier, E ;
Fessi, H .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2004, 280 (1-2) :241-251
[4]   DRUG-RESISTANCE IN SCHISTOSOMES [J].
CIOLI, D ;
PICAMATTOCCIA, L ;
ARCHER, S .
PARASITOLOGY TODAY, 1993, 9 (05) :162-166
[5]  
Coelho P. M. Z., 1997, Revista do Instituto de Medicina Tropical de Sao Paulo, V39, P101, DOI 10.1590/S0036-46651997000200007
[6]   Enhanced schistosomicidal efficacy of tartar emetic encapsulated in pegylated liposomes [J].
de Melo, AL ;
Silva-Barcellos, NM ;
Demicheli, C ;
Frézard, F .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2003, 255 (1-2) :227-230
[7]   The global epidemiological situation of schistosomiasis and new approaches to control and research [J].
Engels, D ;
Chitsulo, L ;
Montresor, A ;
Savioli, L .
ACTA TROPICA, 2002, 82 (02) :139-146
[8]   DRUG-RESISTANT SCHISTOSOMIASIS - RESISTANCE TO PRAZIQUANTEL AND OXAMNIQUINE INDUCED IN SCHISTOSOMA-MANSONI IN MICE IS DRUG-SPECIFIC [J].
FALLON, PG ;
DOENHOFF, MJ .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1994, 51 (01) :83-88
[9]  
Frezard Frederic, 1997, Revista do Instituto de Medicina Tropical de Sao Paulo, V39, P97, DOI 10.1590/S0036-46651997000200006
[10]  
Georgieva K., 1999, Experimental Pathology and Parasitology, V3, P32